Back to Utah

HB0246 • 2026

Local Government Drug Testing Amendments

Local Government Drug Testing Amendments

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Rep. Maloy, A. Cory
Last action
2026-03-17
Official status
Governor Signed
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Local Government Drug Testing Amendments

This bill amends government entity drug testing provisions.

What This Bill Does

  • This bill amends government entity drug testing provisions.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-17 Lieutenant Governor's office for filing

    Governor Signed

  2. 2026-03-11 Clerk of the House

    House/ received enrolled bill from Printing

  3. 2026-03-11 Executive Branch - Governor

    House/ to Governor

  4. 2026-03-04 Clerk of the House

    Enrolled Bill Returned to House or Senate

  5. 2026-03-04 Clerk of the House

    House/ enrolled bill to Printing

  6. 2026-02-27 Legislative Research and General Counsel / Enrolling

    Bill Received from House for Enrolling

  7. 2026-02-27 Legislative Research and General Counsel / Enrolling

    Draft of Enrolled Bill Prepared

  8. 2026-02-25 House Speaker

    House/ received from Senate

  9. 2026-02-25 Legislative Research and General Counsel / Enrolling

    House/ signed by Speaker/ sent for enrolling

  10. 2026-02-25 Senate Consent Calendar

    Senate/ 3rd reading

  11. 2026-02-25 Senate President

    Senate/ passed 3rd reading

  12. 2026-02-25 House Speaker

    Senate/ signed by President/ returned to House

  13. 2026-02-25 House Speaker

    Senate/ to House

  14. 2026-02-20 Senate Consent Calendar

    Senate/ 2nd reading

  15. 2026-02-20 Senate Education Committee

    Senate/ comm rpt/ placed on Consent Calendar

  16. 2026-02-19 Senate Education Committee

    Senate Comm - Consent Calendar Recommendation

  17. 2026-02-19 Senate Education Committee

    Senate Comm - Favorable Recommendation

  18. 2026-02-10 Senate Education Committee

    Senate/ to standing committee

  19. 2026-02-06 House Consent Calendar

    House/ 3rd reading

  20. 2026-02-06 Senate Secretary

    House/ passed 3rd reading

  21. 2026-02-06 Senate Secretary

    House/ to Senate

  22. 2026-02-06 Senate Rules Committee

    Senate/ 1st reading (Introduced)

  23. 2026-02-06 Waiting for Introduction in the Senate

    Senate/ received from House

  24. 2026-02-04 House Consent Calendar

    House/ 2nd reading

  25. 2026-02-04 House Political Subdivisions Committee

    House/ comm rpt/ placed on Consent Calendar

  26. 2026-02-03 House Political Subdivisions Committee

    House Comm - Consent Calendar Recommendation

  27. 2026-02-03 House Political Subdivisions Committee

    House Comm - Favorable Recommendation

  28. 2026-02-02 House Political Subdivisions Committee

    House/ to standing committee

  29. 2026-01-20 House Rules Committee

    House/ 1st reading (Introduced)

  30. 2026-01-20 Clerk of the House

    House/ received fiscal note from Fiscal Analyst

  31. 2026-01-17 Released

    LFA/ fiscal note publicly available for HB0246

  32. 2026-01-17 Version Sponsor

    LFA/ fiscal note sent to sponsor for HB0246

  33. 2026-01-14 Clerk of the House

    House/ received bill from Legislative Research

  34. 2026-01-13 Legislative Research and General Counsel

    Bill Numbered but not Distributed

  35. 2026-01-13 Legislative Fiscal Analyst

    LFA/ bill assigned to staff for fiscal analysis for HB0246

  36. 2026-01-13 Legislative Fiscal Agency

    LFA/ bill sent to agencies for fiscal input for HB0246

  37. 2026-01-13 Legislative Research and General Counsel

    Numbered Bill Publicly Distributed

Official Summary Text

This bill amends government entity drug testing provisions.

Current Bill Text

Read the full stored bill text
14
34-41-101
34-41-103
34-41-104
0
Local Government Drug Testing Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: A. Cory Maloy
Senate Sponsor: Heidi Balderree
LONG TITLE
General Description:
This bill amends government entity drug testing provisions.
Highlighted Provisions:
This bill:
modifies the definition of "sample" to include oral fluid;
clarifies the type of sample that a local governmental entity or state institution of higher
education may require that a donor submit for drug testing; and
requires that sample collection be performed in accordance with instructions prepared by
an independent entity.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
34-41-101
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
34-41-103
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
34-41-104
, as last amended by Laws of Utah 2025, First Special Session, Chapter 9
Be it enacted by the Legislature of the state of Utah:
Section 1. Section
34-41-101
is amended to read:
34-41-101
. Definitions.
As used in this chapter:
(1)
"Donor" means an employee, a volunteer, a prospective employee, or a prospective
volunteer of a local government entity or an institution of higher education.
(2)
"Drug" means any substance recognized as a drug in the United States Pharmacopeia,
the National Formulary, the Homeopathic
Pharmacopeia
Pharmacopoeia
, or other drug
compendia, including Title
58, Chapter 37
, Utah Controlled Substances Act, or
supplement to any of those compendia.
(3)
"Drug testing" means the scientific analysis for the presence of drugs or their
metabolites in the human body in accordance with the definitions and terms of this
chapter.
(4)
"Institution of higher education" means the same as that term is defined in Section
53H-1-101
.
(5)
"Local governmental employee" means any person or officer in the service of a local
governmental entity or institution of higher education for compensation.
(6)
(a)
"Local governmental entity" means any political subdivision of Utah including
any county, municipality, local school district, special district, special service district,
or any administrative subdivision of those entities.
(b)
"Local governmental entity" does not mean Utah state government or its
administrative subdivisions provided for in Sections
63A-17-1001
through
63A-17-1006
.
(7)
"Periodic testing" means preselected and preannounced drug testing of employees or
volunteers conducted on a regular schedule.
(8)
"Prospective employee" means any person who has made a written or oral application to
become an employee of a local governmental entity or an institution of higher education.
(9)
"Random testing" means the unannounced drug testing of an employee or volunteer
who was selected for testing by using a method uninfluenced by any personal
characteristics other than job category.
(10)
"Reasonable suspicion for drug testing" means an articulated belief based on the
recorded specific facts and reasonable inferences drawn from those facts that a local
government employee or volunteer is in violation of the drug-free workplace policy.
(11)
"Rehabilitation testing" means unannounced but preselected drug testing done as part
of a program of counseling, education, and treatment of an employee or volunteer in
conjunction with the drug-free workplace policy.
(12)
"Safety sensitive position" means any local governmental or institution of higher
education position involving duties which directly affects the safety of governmental
employees, the general public, or positions where there is access to controlled
substances, as defined in Title
58, Chapter 37
, Utah Controlled Substances Act, during
the course of performing job duties.
(13)
"Sample" means urine, blood, breath,
saliva
oral fluid
, or hair.
(14)
"Volunteer" means any person who donates services as authorized by the local
governmental entity or institution of higher education without pay or other
compensation except expenses actually and reasonably incurred.
Section 2. Section
34-41-103
is amended to read:
34-41-103
. Policy requirements.
(1)
(a)
A local governmental entity or institution of higher education may not test a donor
for the presence of drugs, unless the local government entity or institution of higher
education:
(i)
adopts a written policy or ordinance for the testing;
(ii)
distributes the policy or ordinance to employees and volunteers; and
(iii)
makes the policy or ordinance available for review by prospective employees
and prospective volunteers.
(b)
The local governmental entity or institution of higher education may only test or
retest for the presence of drugs in accordance with the policy or ordinance described
in Subsection
(1)(a)
.
(2)
The local government entity or institution of higher education:
(a)
shall collect and test samples in accordance with Section
34-41-104
; and
(b)
if otherwise permitted by law, is not limited only to collecting or testing in
circumstances where there are indications of job-related impairment of an employee
or volunteer.
(3)
The use and disposition of all drug test results are subject to the limitations of Title
63G,
Chapter 2
, Government Records Access and Management Act, and the Americans with
Disabilities Act of 1990, 42 U.S.C. 12101 through 12213.
(4)
A donor who is subject to testing under a policy or ordinance described in Subsection
(1)(a)
shall:
(a)
submit
an oral
a blood, breath, oral fluid, or hair
sample for testing; or
(b)
submit a split urine sample for testing or retesting.
(5)
Unless the policy or ordinance described in Subsection
(1)(a)
provides otherwise, the
local governmental entity or institution of higher education may specify the type of
sample, described in Subsection
(4)
, that the donor is required to submit.
(6)
A split urine sample shall consist of at least 45 milliliters of urine, divided into two
specimen bottles with:
(a)
at least 30 milliliters of urine in one bottle, for the initial test; and
(b)
at least 15 milliliters of urine in the other bottle for retesting, if requested under
Subsection
(7)
.
(7)
If the test results of a
urine or oral
sample
test indicate the presence of drugs, the local
governmental entity or institution of higher education shall:
(a)
give notice to the donor:
(i)
of the test results; and
(ii)
for a urine test, that the donor may, within 72 hours after the local government
entity or institution of higher education provides the notice, request testing of the
second sample; and
(b)
test the second sample if the donor timely requests testing of the second sample.
(8)
The expense of testing the second urine sample will be equally divided between the
donor and the local governmental entity or institution of higher education.
(9)
The test results of the samples shall be considered at any subsequent disciplinary
hearing if the requirements of this section and Section
34-41-104
are complied with in
the collection, handling, and testing of the samples.
Section 3. Section
34-41-104
is amended to read:
34-41-104
. Requirements for identification, collection, and testing of samples.
(1)
The local governmental entity or institution of higher education shall ensure that:
(a)
all sample collection under this chapter is performed
in accordance with instructions
prepared
by an entity independent of the local government or institution of higher
education;
(b)
all testing for drugs under this chapter is performed by an independent laboratory
certified for employment drug testing by either the Substance Abuse and Mental
Health Services Administration or the College of American
Pathology
Pathologists
;
(c)
the instructions, chain of custody forms, and collection kits, including containers and
seals, used for sample collection are prepared by an independent laboratory certified
for employment drug testing by either the Substance Abuse and Mental Health
Services Administration or the College of American
Pathology
Pathologists
; and
(d)
sample collection and testing for drugs under this chapter is in accordance with the
requirements of this section.
(2)
The local governmental entity or institution of higher education may:
(a)
in accordance with a policy or ordinance described in Subsection
34-41-103(1)(a)
,
require samples from a donor;
(b)
require presentation of reliable identification to the person collecting the samples; and
(c)
in order to dependably test for the presence of drugs, designate the type of sample to
be used for testing.
(3)
The local governmental entity or institution of higher education shall ensure that the
local governmental entity's or institution of higher education's ordinance or policy
requires that:
(a)
the collection of samples is performed under reasonable and sanitary conditions;
(b)
samples are collected and tested:
(i)
to ensure the privacy of the individual being tested; and
(ii)
in a manner reasonably calculated to prevent substitutions or interference with the
collection or testing of reliable samples;
(c)
sample collection is appropriately documented to ensure that:
(i)
samples are labeled and sealed to reasonably preclude the probability of
erroneous identification of test results; and
(ii)
a donor has the opportunity to provide notification of any information:
(A)
that a donor considers relevant to the test, including identification of currently
or recently used prescription or nonprescription drugs or other relevant medical
information; and
(B)
in compliance with the Americans with Disabilities Act of 1990, 42 U.S.C.
12101 through 12213;
(d)
sample collection, storage, and transportation to the place of testing are performed in
a manner that reasonably precludes the probability of sample misidentification,
contamination, or adulteration; and
(e)
sample testing conforms to scientifically accepted analytical methods and procedures.
(4)
Before the result of any test may be used as a basis for any action by a local
governmental entity or institution of higher education under Section
34-41-105
, the local
governmental entity or institution of higher education shall:
(a)
verify or confirm any positive initial screening test by gas chromatography, gas
chromatography-mass spectroscopy, or other comparably reliable analytical methods;
and
(b)
provide the notice described in Subsection
34-41-103(7)
, as soon as possible after a
positive test result, at the last known address or telephone number of the donor.
(5)
Any drug testing
Except for drug testing of a prospective employee or a prospective
volunteer, drug testing
by a local governmental entity or institution of higher education
shall occur during or immediately after the regular work period of the employee or
volunteer and shall be considered as work time for purposes of compensation and
benefits.
(6)
The local governmental entity or institution of higher education shall pay
:
(a)

all costs of sample collection and initial testing for drugs required under the policy
or ordinance described in Subsection
34-41-103(1)(a)
,
; and
(b)
including the costs of transportation if the testing of an
if the donor is a current

employee or
current
volunteer
and testing
is conducted at a place other than the
workplace
, the cost of transportation to the testing location
.
Section 4.
Effective Date.
This bill takes effect on
May 6, 2026
.
2-27-26 8:42 AM